Literature DB >> 12505263

Frequency of 657del(5) mutation of the NBS1 gene in the Czech population by polymerase chain reaction with sequence specific primers.

Jirí Drábek1, Marián Hajdúch, Libuse Gojová, Evzen Weigl, Vladimír Mihál.   

Abstract

Nijmegen breakage syndrome is an autosomal recessive chromosomal instability syndrome characterized by microcephaly, immunodeficiency, radiosensitivity, and predisposition to lymphoid malignancy. A truncating deletion [657del(5)] in exon 6 of the nibrin NBS1 gene is the most frequent cause of the syndrome. Slavic populations carry this mutation in a high frequency. Here, we present polymerase chain reaction with sequence specific primers as a method for the detection of Slavic NBS1 mutation and confirm the high carrier frequency in the Czech population (combined frequency from both studies: 1/106, 95% CI = 1/331 to 1/46).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12505263     DOI: 10.1016/s0165-4608(02)00594-0

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

1.  High prevalence of the NBN gene mutation c.657-661del5 in Southeast Germany.

Authors:  M H Maurer; K Hoffmann; K Sperling; R Varon
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

2.  Heterozygous carriers of Nijmegen Breakage Syndrome have a distinct gene expression phenotype.

Authors:  Vivian G Cheung; Warren J Ewens
Journal:  Genome Res       Date:  2006-06-29       Impact factor: 9.043

3.  Regional distribution of heterozygous 657del5 mutation carriers of the NBS1 gene in Wielkopolska province (Poland).

Authors:  Iwona Ziółkowska; Maria Mosor; Jerzy Nowak
Journal:  J Appl Genet       Date:  2006       Impact factor: 2.653

4.  The Slavic NBN Founder Mutation: A Role for Reproductive Fitness?

Authors:  Eva Seemanova; Raymonda Varon; Jan Vejvalka; Petr Jarolim; Pavel Seeman; Krystyna H Chrzanowska; Martin Digweed; Igor Resnick; Ivo Kremensky; Kathrin Saar; Katrin Hoffmann; Véronique Dutrannoy; Mohsen Karbasiyan; Mehdi Ghani; Ivo Barić; Mustafa Tekin; Peter Kovacs; Michael Krawczak; André Reis; Karl Sperling; Michael Nothnagel
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.